Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instead Sciences is a consumer health company dedicated to providing healthier alternatives for smokers and vapers. Founded by Zocdoc co-founder Cyrus Massoumi, the company's primary offering is a nicotine-free and tobacco-free product designed to replicate the sensory experience of smoking using a proprietary botanical blend. By addressing the behavioral rituals of smoking without the addictive properties of nicotine, Instead Sciences aims to support individuals in their journey toward a nicotine-free lifestyle. The company is backed by prominent venture capital firms and focuses on the intersection of consumer goods and behavioral health. Instead Sciences is currently in the commercial stage, offering its flagship product directly to consumers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instead Sciences.